Advance novel, late-stage Investigational ophthalmology drugs OCS-01 and OCS-02 and deliver the first topical drug for retinal edema. Expand Oculis pipeline of innovative ophthalmology candidates ...
HOUSTON and SHANGHAI, Nov. 4, 2021 /PRNewswire/ -- Cellenkos® Inc. ("Cellenkos"), a biotech company focused on developing transformative novel T regulatory (Treg) cell therapies to treat autoimmune ...
HAYWARD, Calif. and SHANGHAI, Aug. 22, 2013 /PRNewswire/ -- MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced it raised ...
DiaCarta, Inc., a privately-held biotechnology company raised $8 million in Series A financing from BVCF (BioVeda China Fund). Proceeds from Series A financing will be used to expand the product ...
MINNEAPOLIS, June 8, 2011 (GLOBE NEWSWIRE) -- SPS Commerce (Nasdaq:SPSC), a leading provider of on-demand supply chain management solutions, today announced the commencement of a public offering of ...
Having recently secured just under $200 million for a new fund to invest in China's health-care and life sciences industry, BVCF Managing Partner Zhi Yang talked to Venture Capital Dispatch on how the ...
SHANGHAI -- CARsgen, a leader in the development of Chimeric Antigen Receptors T (CAR-T) cell immunotherapy to treat a variety of cancers, today announced the completion of a series A financing led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results